Chris Hill
1.5K posts
Chris Hill
@dochill82
Dad, kidney doc, Liverpool FC fan, cricket follower and TMS fanatic. #YNWA
Katılım Eylül 2015
81 Takip Edilen256 Takipçiler
Chris Hill retweetledi
PARAMEDIC3 & IVIO trials presented at #RESUS24 & published in @NEJM
IV vs IO access in out-of-hospital cardiac arrest - largely similar outcomes
CCR Journal Watch
criticalcarereviews.com/latest-evidenc…
The latest crit care literature every weekend via CCR Newsletter - criticalcarereviews.com/newsletters/su…
English
Question for #NephX #NephTwitter -
hswapnil: @dochill82 @askrenal Your account is locked - so won’t be seen by many people sorry! twitter.com/hswapnil/statu…
Swapnil Hiremath @hswapnil.medsky.social@hswapnil
@dochill82 @askrenal Your account is locked - so won’t be seen by many people sorry!
English
Chris Hill retweetledi
B-cell activating factor and A proliferation-inducing ligand play key roles in the pathogenesis of IgA nephropathy. This study found that atacicept treatment reduced Gd-IgA1, hematuria, and UPCR with stabilization of eGFR through 96 weeks. bit.ly/JASN0541
#KidneyWk
#LBCT
English
Chris Hill retweetledi
Original Article: Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy (APPLAUSE-IgAN) nej.md/3UmrOkh
Editorial: Waystations in Progress — Burgeoning Treatment Options for IgA Nephropathy nej.md/4fdz9dV
#KidneyWk | @ASNKidney
English
Chris Hill retweetledi
How do patients experience a kidney biopsy?
Our paper explores how to facilitate access to this essential investigation.
Big thanks to the patient participants for guiding this project!
@NIKRFcharity @TEAM_TSNI @kidneycareuk
doi.org/10.1371/journa…
English
10 years as a consultant in the NHS today… Where did that decade go?
English
Chris Hill retweetledi
The Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) from @goKDIGO is out for public review ‼️
#KDIGOIgAN #Nephpearls
📌 Submit comments by Sept 30 🗓️
👉 kdigo.org/guidelines/iga…
Riverside, IL 🇺🇸 English
Chris Hill retweetledi
A meta-analysis of randomized controlled clinical trials for implications of acute treatment effects on glomerular filtration rate for long-term #kidney protection
doi.org/10.1016/j.kint…
@univgroningen @utahctsi @TuftsMCResearch @CUDeptMedicine @radboudumc
#GFR #kidneyfailure
English
Encouraging results - a drug that may be able to stop chronic AMR in its tracks… The 1 year eGFR slopes look very encouraging but why no improvement in proteinuria?
NEJM@NEJM
Original Article: A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection: nej.md/4dHQhsa Editorial: Felzartamab and Antibody-Mediated Rejection in Kidney Transplants — Hope at Last? nej.md/3S2aGPk #Nephrology
English
Chris Hill retweetledi
Original Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW) nej.md/44U3slP
Editorial: Diabetic Kidney Disease — Semaglutide Flows into the Mainstream nej.md/4cROKP6
#Nephrology
English
Chris Hill retweetledi
RaDaR: In this IgA Nephropathy #IgAN cohort, patients traditionally regarded as being low risk, with proteinuria <0.88 g/g (<100 mg/mmol), had high rates of kidney failure within 10 years ca. 2024 from @CJASN #Nephpearls #NephJC
👉 pubmed.ncbi.nlm.nih.gov/37055195/
English
Chris Hill retweetledi
COVID vaccines are associated with lower risk of death and hospitalization following covid infection. Three doses are better than two doses which are better than no doses.
journals.lww.com/kidney360/cita…
English
Most convincing evidence yet for making GLP-1RA combined with SGLT2i standard of care in Type 2 DM. Saves kidneys, hearts and lives!
Brendon Neuen@brendonneuen
Our #SMARTC collaborative meta-analysis is now in @TheLancetEndo: Data from >73,000 people across 12 trials provides the strongest evidence yet for combined use of SGLT2i & GLP-1RA to improve clinical outcomes in diabetes Download free for 50 days here: authors.elsevier.com/a/1jOfA7tNucqx…
English
Chris Hill retweetledi
Our #SMARTC collaborative meta-analysis is now in @TheLancetEndo:
Data from >73,000 people across 12 trials provides the strongest evidence yet for combined use of SGLT2i & GLP-1RA to improve clinical outcomes in diabetes
Download free for 50 days here: authors.elsevier.com/a/1jOfA7tNucqx…
English
Chris Hill retweetledi
Busy week ahead presenting our results at #UKKW2024 & #INS24 . Manuscript almost ready for submission too.
Thanks all who participated!
@kidney_boy @hswapnil @nkf
English
Chris Hill retweetledi
A Phase II randomized controlled trial evaluated antithrombotic treatment with #fesomersen in patients with #kidneyfailure on #hemodialysis
doi.org/10.1016/j.kint…
@BCMDeptMedicine @EmoryNephrology @MacDeptMed @StanfordDeptMed @SCCR_Stanford
@HamHealthSci #ESKD
English
Chris Hill retweetledi
Kidney Dysfunction in the Setting of Liver Failure: Core Curriculum 2024
buff.ly/3NoEcfZ (FREE)
@SwethaKanduriMD @VelezNephHepato @OchsnerNephro
English